2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab

Clinical trial NCT00600340 · COMPLETED

Trial details

NCT number: NCT00600340
Sponsor: Central European Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2008-04-01
Primary completion: 2014-09-01
Enrollment: 564

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.